Icosapent Ethyl Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 1 g

Reference Brands: Vascepa (USA), Vazkepa (EU/UK)

Category: Heart Disorder

Icosapent ethyl is a highly purified ethyl ester of eicosapentaenoic acid (EPA), an omega-3 fatty acid. It is used alongside statin therapy in adults with elevated triglycerides to reduce the risk of cardiovascular events such as heart attack and stroke. Icosapent Ethyl is available in Capsules and strengths such as 1 g. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Icosapent Ethyl is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Icosapent Ethyl can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Icosapent ethyl (IPE) is a high-purity prescription form of eicosapentaenoic acid ethyl ester, primarily used as an adjunct to diet for managing elevated triglyceride levels in adults. It is approved by the US Food and Drug Administration for the treatment of severe hypertriglyceridemia (triglycerides ≥500 mg/dL). IPE works by reducing triglyceride levels, as well as non-high-density lipoprotein (non-HDL) cholesterol and apolipoprotein B, without significantly increasing low-density lipoprotein cholesterol (LDL-C).

Clinical studies, including the MARINE and ANCHOR trials, have demonstrated that IPE effectively lowers triglycerides in patients with both very high levels (≥500 mg/dL) and moderately elevated levels (200–500 mg/dL) despite well-controlled LDL-C. Beyond its lipid-lowering effects, IPE has been shown to have beneficial effects on inflammatory markers, supporting its role in cardiovascular risk management.

Taken as part of a comprehensive lipid-lowering strategy alongside diet and lifestyle modifications, icosapent ethyl provides an important therapeutic option for patients at risk of cardiovascular disease due to high triglycerides. Its targeted action helps improve lipid profiles and contributes to the overall reduction of cardiovascular risk in adults with hypertriglyceridemia.